Thrombolytic agents, including tenecteplase, are generally used within 4.5 hours after the onset of stroke symptoms. Information on whether tenecteplase confers benefit beyond 4.5 hours is limited. We ...
Dr. Scott B. Silverman: A 68-year-old man was admitted to this hospital because of worsening confusion. The patient had a history of hypertension and coronary artery disease. A myocardial infarction ...
Tenecteplase improved functional outcomes without added safety risk in selected basilar artery occlusion stroke treated up to 24 hours after onset in the TRACE-5 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback